Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Harneet, Bhatti"'
Publikováno v:
The Annals of pharmacotherapy.
Background: Haloperidol can be used off-label for agitation and/or delirium in older individuals. The recommended initial intramuscular or intravenous dose is 0.5 to 1 mg. However, the evidence to support these doses is nominal. Objectives: The prima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c64ec6c335494147d500723fe11361
https://pubmed.ncbi.nlm.nih.gov/36113417
https://pubmed.ncbi.nlm.nih.gov/36113417
Autor:
Harneet, Bhatti, Andres, Cordova Sanchez, Rajat, Dhungana, Christos, Carvounis, Avneet, Singh
Publikováno v:
Cureus.
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, is an ongoing pandemic that has affected millions globally. Many infected patients have been noted to have cardiovascular damage. Prior to the develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0bb873ca681cfe0699ea30e1ef9828
https://doi.org/10.7759/cureus.23986
https://doi.org/10.7759/cureus.23986
Publikováno v:
J Atr Fibrillation
BACKGROUND: Atrial fibrillation is currently managed with a variety of rate controlling and antiarrhythmic agents. Often, magnesium is used as adjunctive therapy, however, the benefit it provides in managing Afib with RVR has been debated. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45b72fbbcfa11dd5d740fee83ded820d
https://pubmed.ncbi.nlm.nih.gov/34950320
https://pubmed.ncbi.nlm.nih.gov/34950320
Publikováno v:
Journal of the American College of Cardiology. 77:2899
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d296c8d1bd3604ae1501b029f927df48
https://doi.org/10.1016/s0735-1097(21)04254-6
https://doi.org/10.1016/s0735-1097(21)04254-6
Autor:
Antonio Costeira Pereira, Roman Zeltser, Harneet Bhatti, Jody C. DiGiacomo, Supreeya Swarup, Amgad N. Makaryus
Publikováno v:
Journal of the American College of Cardiology. 71:A127
Cardiac troponin I (TnI) is a cardiac specific regulatory protein that has been proven to be important in tracking myocardial cell injury and future mortality. Studies have proposed increases in TnI can often identify cardiovascular (CV) complication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec6a74e40449f887ed02aaad21fe2a5d
https://doi.org/10.1016/s0735-1097(18)30668-5
https://doi.org/10.1016/s0735-1097(18)30668-5